Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 1
1993 2
1994 1
1995 1
1996 1
1997 1
1998 1
1999 1
2000 1
2001 2
2003 3
2004 3
2005 5
2006 5
2009 1
2010 1
2012 1
2017 1
2018 6
2019 11
2020 6
2021 8
2022 15
2023 10
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

86 results

Results by year

Filters applied: . Clear all
Page 1
Low dose, add-on prednisolone in patients with rheumatoid arthritis aged 65+: the pragmatic randomised, double-blind placebo-controlled GLORIA trial.
Boers M, Hartman L, Opris-Belinski D, Bos R, Kok MR, Da Silva JA, Griep EN, Klaasen R, Allaart CF, Baudoin P, Raterman HG, Szekanecz Z, Buttgereit F, Masaryk P, Klausch LT, Paolino S, Schilder AM, Lems WF, Cutolo M; GLORIA Trial consortium. Boers M, et al. Among authors: kok mr. Ann Rheum Dis. 2022 Jul;81(7):925-936. doi: 10.1136/annrheumdis-2021-221957. Epub 2022 May 31. Ann Rheum Dis. 2022. PMID: 35641125 Free PMC article. Clinical Trial.
Intervention with methotrexate in patients with arthralgia at risk of rheumatoid arthritis to reduce the development of persistent arthritis and its disease burden (TREAT EARLIER): a randomised, double-blind, placebo-controlled, proof-of-concept trial.
Krijbolder DI, Verstappen M, van Dijk BT, Dakkak YJ, Burgers LE, Boer AC, Park YJ, de Witt-Luth ME, Visser K, Kok MR, Molenaar ETH, de Jong PHP, Böhringer S, Huizinga TWJ, Allaart CF, Niemantsverdriet E, van der Helm-van Mil AHM. Krijbolder DI, et al. Among authors: kok mr. Lancet. 2022 Jul 23;400(10348):283-294. doi: 10.1016/S0140-6736(22)01193-X. Lancet. 2022. PMID: 35871815 Clinical Trial.
Window of opportunity in psoriatic arthritis: the earlier the better?
Snoeck Henkemans SVJ, de Jong PHP, Luime JJ, Kok MR, Tchetverikov I, Korswagen LA, van der Kooij SM, van Oosterhout M, Baudoin P, Bijsterbosch J, van der Kaap JH, van der Helm-van Mil AHM, Vis M. Snoeck Henkemans SVJ, et al. Among authors: kok mr. RMD Open. 2024 Feb 27;10(1):e004062. doi: 10.1136/rmdopen-2023-004062. RMD Open. 2024. PMID: 38413172 Free PMC article.
Three-month tapering and discontinuation of long- term, low-dose glucocorticoids in senior patients with rheumatoid arthritis is feasible and safe: placebo-controlled double blind tapering after the GLORIA trial.
Almayali AAH, Boers M, Hartman L, Opris D, Bos R, Kok MR, Da Silva JA, Griep E, Klaasen R, Allaart CF, Baudoin P, Raterman HG, Szekanecz Z, Buttgereit F, Masaryk P, Lems W, Smulders Y, Cutolo M, Ter Wee MM. Almayali AAH, et al. Among authors: kok mr. Ann Rheum Dis. 2023 Oct;82(10):1307-1314. doi: 10.1136/ard-2023-223977. Epub 2023 Aug 4. Ann Rheum Dis. 2023. PMID: 37541762 Clinical Trial.
Advances in vector-mediated gene transfer.
Baum BJ, Goldsmith CM, Kok MR, Lodde BM, van Mello NM, Voutetakis A, Wang J, Yamano S, Zheng C. Baum BJ, et al. Among authors: kok mr. Immunol Lett. 2003 Dec 15;90(2-3):145-9. doi: 10.1016/j.imlet.2003.08.006. Immunol Lett. 2003. PMID: 14687716 Review.
Capturing Patient Value in an Economic Evaluation.
Koster F, Kok MR, Lopes Barreto D, Weel-Koenders AEAM. Koster F, et al. Among authors: kok mr. Arthritis Care Res (Hoboken). 2024 Feb;76(2):191-199. doi: 10.1002/acr.25229. Epub 2023 Dec 16. Arthritis Care Res (Hoboken). 2024. PMID: 37667586
86 results